Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Jul 27, 2026; 18(7): 121776
Published online Jul 27, 2026. doi: 10.4240/wjgs.v18.i7.121776
Published online Jul 27, 2026. doi: 10.4240/wjgs.v18.i7.121776
Table 3 Comparison of adverse reaction incidence between two patient groups, n (%)
| Parameters | OG | CG | χ2 | P value |
| Induction injection pain | 1 (1.69) | 19 (32.20) | 20.338 | < 0.001 |
| Bradycardia | 2 (3.39) | 11 (18.64) | 7.002 | 0.008 |
| Hypotension | 4 (6.78) | 16 (27.12) | 8.669 | 0.003 |
| Post-extubation respiratory depression | 0 | 0 | - | - |
| Hypoxemia | 1 (1.69) | 3 (5.08) | 1.035 | 0.309 |
| Delayed emergence from anesthesia | 1 (1.69) | 1 (1.69) | - | - |
| Dizziness and headache | 0 | 0 | - | - |
| Agitation | 1 (1.69) | 1 (1.69) | - | - |
| Somnolence | 1 (1.69) | 0 | 1.009 | 0.315 |
| Delirium | 0 | 0 | - | - |
| Total adverse reactions1 | 9 (15.25) | 27 (45.76) | 12.951 | 0.001 |
- Citation: Wang QW, Wu L, Wang ZQ, Zhang J, Bai SC. Clinical application of remimazolam benzenesulfonate in elderly patients undergoing laparoscopic cholecystectomy under intravenous general anesthesia. World J Gastrointest Surg 2026; 18(7): 121776
- URL: https://www.wjgnet.com/1948-9366/full/v18/i7/121776.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v18.i7.121776